US › Healthcare

Daxor Corporation (DXR)

US · Healthcare · Medical Instruments & Supplies

$10.05-1.47%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$23,020

Revenue YoY

-67.9%

Net profit

$-3.3M

Net margin

-14,382.9%

Key statistics

Market cap

$60.8M

P/E

9.5

Forward P/E

64.5

P/B

1.22

Book value

$8.88

EPS (TTM)

$1.10

52-week high

$14.76

52-week low

$8.56

50-day MA

$10.66

200-day MA

$11.05

Beta

0.35

Analyst view

Analysts rate Daxor Corporation a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $20.00.

Shareholding

Insiders

49.50%

Institutions

7.02%

Largest institutional holders

Fund	Stake
Thompson, Siegel & Walmsley LLC	4.14%
Vanguard Capital Management, LLC	0.84%
Aristides Capital LLC	0.71%
Renaissance Technologies Corp	0.50%
Susquehanna International Group, LLP	0.46%
NANO CAP NEW MILLENNIUM GROWTH FUND L P	0.21%
Crescent Grove Advisors, LLC	0.21%
SBI Securities Co Ltd	0.05%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Daxor Corporation — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.